These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 182335)

  • 1. Effects of a diphosphonate (disodium etidronate: EHDP) on phosphate metabolism in Paget's disease of bone, primary hyperparathyroidism and type I hypophosphataemic rickets.
    Walton RJ; Smith R; Russell RG
    Calcif Tissue Res; 1976 Aug; 21 Suppl():339-43. PubMed ID: 182335
    [No Abstract]   [Full Text] [Related]  

  • 2. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
    Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of prolonged treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP).
    De Vries HR; Bijvoet OL
    Neth J Med; 1974; 17(6):281-98. PubMed ID: 4280525
    [No Abstract]   [Full Text] [Related]  

  • 4. Tubular excretion of phosphate in Paget's disease of bone. Effect of pamidronate.
    Constantin A; Laroche M; Moulinier L; Bon E; Ramonjisoa M; Cantagrel A; Mazieres B
    Rev Rhum Engl Ed; 1995; 62(7-8):493-500. PubMed ID: 8574612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man.
    Walton RJ; Russell RG; Smith R
    Clin Sci Mol Med; 1975 Jul; 49(1):45-56. PubMed ID: 807449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
    Hosking DJ; Bijvoet OL
    Calcif Tissue Res; 1976 Aug; 21 Suppl():321-6. PubMed ID: 821599
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
    Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
    Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phosphate diabetes and Paget's disease: 2 cases].
    Laroche M; Arlet J; Ader JL; Tran Van T; Mazières B
    Rev Rhum Mal Osteoartic; 1991; 58(7):497-9. PubMed ID: 1925394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP).
    Johnston CC; Altman RD; Canfield RE; Finerman GA; Taulbee JD; Ebert ML
    Clin Orthop Relat Res; 1983; (172):186-94. PubMed ID: 6401608
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate.
    de Vries HR; Bijvoet OL; Froeling PG
    J Endocrinol; 1975 Mar; 64(3):51P. PubMed ID: 805820
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperparathyroidism in Paget's disease of bone.
    Gay JD; Poznanski WJ
    Clin Invest Med; 1983; 6(2):97-101. PubMed ID: 6309450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide uptake studies of bone: a quantitative method of evaluating the response of patients with Paget's disease to diphosphonate therapy.
    Goldman AB; Braunstein P; Wilkinson D; Kammerman S
    Radiology; 1975 Nov; 117(2):365-9. PubMed ID: 809805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
    Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
    Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Paget's disease: errors to be avoided].
    Fournié A; Fournié B; Lassoued S
    Rev Prat; 1989 Apr; 39(13):1143-6. PubMed ID: 2499920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous fractures of uninvolved bones in patients with Paget's disease during unduly prolonged treatment with disodium etidronate (EHDP).
    Mautalen C; Gonzalez D; Blumenfeld EL; Santini Araujo E; Schajowicz F
    Clin Orthop Relat Res; 1986 Jun; (207):150-5. PubMed ID: 3087670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
    Stein I; Shapiro B; Ostrum B; Beller ML
    Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D in Paget's disease of bone.
    Foldes J; Shamir S; Kidroni G; Menczel J
    Clin Orthop Relat Res; 1989 Jun; (243):275-9. PubMed ID: 2498022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone tissue in Paget's disease treated by ethane-1, hydroxy-1, 1 diphosphonate (EHDP). Structure, ultrastructure, and immunocytology.
    Basle MF; Rebel A; Renier JC; Audran M; Filmon R; Malkani K
    Clin Orthop Relat Res; 1984 Apr; (184):281-8. PubMed ID: 6423333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evolution of Paget's disease of bone during and after treatment with small doses of disodium etidronate (EHDP)].
    Reginster JY; Gritten C; Diverse P; Hauwaert C; Halleux R; Franchimont P
    Rev Med Liege; 1985 May; 40(10):417-22. PubMed ID: 3927462
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical, biological and histological effects of ethane-1-hydroxy 1, 1-diphosphonate (EDHP) in Paget's disease].
    Meunier P; Chapuy MC; Courpron P; Vignon E; Edouard C; Bernard J
    Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):699-705. PubMed ID: 817385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.